Abstract PO4-04-02: Real-world First Line Use of Trastuzumab Biosimilar (HLX02), Pertuzumab and Chemotherapy for Chinese Patients with HER2-positive Metastatic Breast Cancer
Cancer Research（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要
Cancer Research（2024）